These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19762545)

  • 41. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
    He B; Kemppainen JA; Wilson EM
    J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1.
    Gonzalez MI; Robins DM
    J Biol Chem; 2001 Mar; 276(9):6420-8. PubMed ID: 11096094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin.
    Li J; Fu J; Toumazou C; Yoon HG; Wong J
    Mol Endocrinol; 2006 Apr; 20(4):776-85. PubMed ID: 16373397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
    He B; Gampe RT; Kole AJ; Hnat AT; Stanley TB; An G; Stewart EL; Kalman RI; Minges JT; Wilson EM
    Mol Cell; 2004 Nov; 16(3):425-38. PubMed ID: 15525515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor.
    Mounir Z; Korn JM; Westerling T; Lin F; Kirby CA; Schirle M; McAllister G; Hoffman G; Ramadan N; Hartung A; Feng Y; Kipp DR; Quinn C; Fodor M; Baird J; Schoumacher M; Meyer R; Deeds J; Buchwalter G; Stams T; Keen N; Sellers WR; Brown M; Pagliarini RA
    Elife; 2016 May; 5():. PubMed ID: 27183006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.
    Askew EB; Bai S; Blackwelder AJ; Wilson EM
    J Biol Chem; 2010 Jul; 285(28):21824-36. PubMed ID: 20448036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction.
    He B; Lee LW; Minges JT; Wilson EM
    J Biol Chem; 2002 Jul; 277(28):25631-9. PubMed ID: 12000757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.
    Askew EB; Bai S; Hnat AT; Minges JT; Wilson EM
    J Biol Chem; 2009 Dec; 284(50):34793-808. PubMed ID: 19828458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
    Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen receptor interacts with a novel MYST protein, HBO1.
    Sharma M; Zarnegar M; Li X; Lim B; Sun Z
    J Biol Chem; 2000 Nov; 275(45):35200-8. PubMed ID: 10930412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism.
    Li S; Liu C; Li N; Hao T; Han T; Hill DE; Vidal M; Lin JD
    Cell Metab; 2008 Aug; 8(2):105-17. PubMed ID: 18680712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control.
    Christiaens V; Bevan CL; Callewaert L; Haelens A; Verrijdt G; Rombauts W; Claessens F
    J Biol Chem; 2002 Dec; 277(51):49230-7. PubMed ID: 12370175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
    Li N; Chen M; Truong S; Yan C; Buttyan R
    Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.
    Hsu CL; Chen YL; Yeh S; Ting HJ; Hu YC; Lin H; Wang X; Chang C
    J Biol Chem; 2003 Jun; 278(26):23691-8. PubMed ID: 12714604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression.
    Burd CJ; Petre CE; Moghadam H; Wilson EM; Knudsen KE
    Mol Endocrinol; 2005 Mar; 19(3):607-20. PubMed ID: 15539430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.